These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29606016)

  • 41. Validation of cellular tests for Lyme borreliosis (VICTORY) study.
    van de Schoor FR; Baarsma ME; Gauw SA; Joosten LAB; Kullberg BJ; van den Wijngaard CC; Hovius JW
    BMC Infect Dis; 2019 Aug; 19(1):732. PubMed ID: 31429716
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Blood cell disruption to significantly improve the Borrelia PCR detection sensitivity in borreliosis in humans.
    Lacout A; Mone Y; Franck M; Marcy PY; Mas M; Veas F; Perronne C
    Med Hypotheses; 2018 Jul; 116():1-3. PubMed ID: 29857888
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An Enzyme-Linked Immunosorbent Spot Assay Measuring Borrelia burgdorferi B31-Specific Interferon Gamma-Secreting T Cells Cannot Discriminate Active Lyme Neuroborreliosis from Past Lyme Borreliosis: a Prospective Study in the Netherlands.
    van Gorkom T; Sankatsing SUC; Voet W; Ismail DM; Muilwijk RH; Salomons M; Vlaminckx BJM; Bossink AWJ; Notermans DW; Bouwman JJM; Kremer K; Thijsen SFT
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29367297
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of genetic variability within the Borrelia burgdorferi sensu lato with the ecology, epidemiology of Lyme borreliosis in Europe.
    Derdáková M; Lencáková D
    Ann Agric Environ Med; 2005; 12(2):165-72. PubMed ID: 16457468
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The prevalence of antibodies against B. burgdorferi, an indicator for Lyme borreliosis in dogs? A comparison of serological tests.
    Goossens HA; Maes JH; van den Bogaard AE
    Tijdschr Diergeneeskd; 2003 Nov; 128(21):650-7. PubMed ID: 14650723
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immune responses to borrelial VlsE IR6 peptide variants.
    Sillanpää H; Lahdenne P; Sarvas H; Arnez M; Steere A; Peltomaa M; Seppälä I
    Int J Med Microbiol; 2007 Feb; 297(1):45-52. PubMed ID: 17234451
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Diagnostics and treatment of Lyme borreliosis].
    Oksi J
    Duodecim; 2000; 116(6):605-12. PubMed ID: 11787113
    [No Abstract]   [Full Text] [Related]  

  • 48. Interpretation criteria for standardized Western blot for the predominant species of Borrelia burgdorferi sensu lato in China.
    Jiang Y; Hou XX; Geng Z; Hao Q; Wan KL
    Biomed Environ Sci; 2010 Oct; 23(5):341-9. PubMed ID: 21112481
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nested-PCR real time as alternative molecular tool for detection of Borrelia burgdorferi compared to the classical serological diagnosis of the blood.
    Sroka-Oleksiak A; Ufir K; Salamon D; Bulanda M; Gosiewski T
    Med Dosw Mikrobiol; 2016; 68(1):47-56. PubMed ID: 28146622
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tired of Lyme borreliosis. Lyme borreliosis in the Netherlands.
    Coumou J; van der Poll T; Speelman P; Hovius JW
    Neth J Med; 2011 Mar; 69(3):101-11. PubMed ID: 21444934
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Seroprevalence of Anaplasma phagocytophilum in patients with suspected Lyme borreliosis].
    Dvořáková Heroldová M; Dvořáčková M
    Epidemiol Mikrobiol Imunol; 2014 Nov; 63(4):297-302. PubMed ID: 25523223
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Laboratory diagnosis of Lyme borreliosis].
    Kristiansen BE; Grude N; Tveten Y; Emmert A
    Tidsskr Nor Laegeforen; 2009 Oct; 129(20):2132-4. PubMed ID: 19855455
    [No Abstract]   [Full Text] [Related]  

  • 53. [Preparations for serodiagnosis of diseases due to causative agents of ixodes tick-borne borreliosis (Lyme disease). Communication 3. Comparative study of enzyme immunoassay test-systems for detection of IgM to Borrelia burgdorferi sensu lato].
    Manzeniuk IN; Vorob'eva MS; Kozarenko AA; Andreĭchuk IuV
    Antibiot Khimioter; 2004; 49(11):12-5. PubMed ID: 15945543
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Biologic diagnosis of Lyme borreliosis].
    Remy V
    Med Mal Infect; 2007; 37(7-8):410-21. PubMed ID: 17360138
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Lyme borreliosis: from the erythema migrans to Lyme arthritis].
    Péter O
    Rev Med Suisse; 2006 Mar; 2(57):727-8, 730-1. PubMed ID: 16604874
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of a multiplex assay for the detection of antibodies to Borrelia burgdorferi in horses and its validation using Bayesian and conventional statistical methods.
    Wagner B; Freer H; Rollins A; Erb HN; Lu Z; Gröhn Y
    Vet Immunol Immunopathol; 2011 Dec; 144(3-4):374-81. PubMed ID: 21890217
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Feedback on difficulties raised by the interpretation of serological tests for the diagnosis of Lyme disease.
    Hansmann Y; Leyer C; Lefebvre N; Revest M; Rabaud C; Alfandari S; Christmann D; Tattevin P
    Med Mal Infect; 2014 May; 44(5):199-205. PubMed ID: 24794819
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Past, Present, and (Possible) Future of Serologic Testing for Lyme Disease.
    Theel ES
    J Clin Microbiol; 2016 May; 54(5):1191-6. PubMed ID: 26865690
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An Australian guideline on the diagnosis of overseas-acquired Lyme disease/borreliosis.
    Lum GD; Hood JR; Wright P
    Commun Dis Intell Q Rep; 2015 Dec; 39(4):E590-6. PubMed ID: 26779732
    [No Abstract]   [Full Text] [Related]  

  • 60. Evaluation of commercial screening tests and blot assays for the diagnosis of Lyme borreliosis.
    Busson L; Reynders M; Van den Wijngaert S; Dahma H; Decolvenaer M; Vasseur L; Vandenberg O
    Diagn Microbiol Infect Dis; 2012 Jul; 73(3):246-51. PubMed ID: 22560168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.